Implementing value-based pricing in the UK
June 14, 2010Sales and Marketing hta, pricing, value
The UK has a strong history of innovation in medicines and it is vital to the economy that this continues …
GSK-funded project will print APIs onto tablets
June 14, 2010Manufacturing and Production, Research and Development GlaxoSmithKline, manufacturing, production, tablets
Researchers at GlaxoSmithKline and two UK universities are working on a technology that could allow active pharmaceutical ingredients to be …
Digital Pharma: NHS Direct pilots online treatment aids
June 11, 2010Medical Communications NHS, NHS Direct, osteoporosis, patient information, prostate cancer
NHS Direct is piloting online decision aids to help patients suffering from osteoporosis or prostate cancer make informed healthcare choices. …
Virgo wins Risperdal UK account
June 11, 2010Medical Communications Janssen, Open Road, Risperdal, Virgo
Janssen-Cilag has called in Virgo Health and Open Road to help boost the fortunes of its injectable antipsychotic drug Risperdal …
GSK acquires Argentine pharma firm
June 11, 2010Sales and Marketing Argentina, GlaxoSmithKline, Latin America, em
GlaxoSmithKline has acquired a leading Argentine pharma firm Laboratorios Phoenix in a move to make further inroads into Latin America. …
BMS factory closure could interrupt HIV drug supply
June 11, 2010Manufacturing and Production BMS, HIV, manufacturing, supply chain
Closure of a manufacturing facility in France operated by Bristol-Myers Squibb could lead to shortages of an important treatment for …
Gilenia on track to become first oral MS drug
June 11, 2010Sales and Marketing Gilenia, MS
Novartis’ oral MS therapy Gilenia has been boosted by an FDA committee’s unanimous recommendation for its approval. The drug is …
Dr. Panos Tsintis joins NDA
June 11, 2010NDA, the leading European regulatory affairs consulting group, appoints Dr Panos Tsintis to its expanding panel of experts – the …
Chiltern Launches Collaborative Technologies
June 11, 2010Research and Development
Glenn Kerkhof, Chiltern CEO, commented, “A key benefit of Collaborative Technologies is the immediate access to current study information which …
PFI schemes should be cut first, say doctors
June 11, 2010NHS, NHS funding
The British Medical Association has put forward its own suggestions about how the NHS can save money, and says private …
Publicis Life Brands Resolute promotes Jenny Plant
June 11, 2010Medical Communications Resolute, appointment, medical communications, publicis
Jenny Plant has been promoted to general manager of Publicis Life Brands Resolute, the coms agency formed through Publicis’ recent …
The Research Partnership makes global appointments
June 11, 2010Sales and Marketing The Research Partnership, appointment, sales and marketing
Market research firm The Research Partnership has made two appointments to its global network of offices. Philippe Pouliot has been …
Zactima promising in rare thyroid cancer
June 11, 2010Research and Development, Sales and Marketing AstraZeneca, thyroid cancer, zactima
AstraZeneca’s Zactima (vandetanib) will be filed with regulators later this year as a treatment for thyroid cancer after promising results. …
Stem cells and patents: a potent mix
June 10, 2010Research and Development Stem cells, stem cell
In recent years, there has been much debate about whether or not the use of stem cells in medical research …
Genzyme and Icahn agree compromise deal
June 10, 2010Research and Development, Sales and Marketing Genzyme
Carl Icahn has won his battle with Genzyme to have his associates given a place on the company’s board.The US …
Study re-opens debate about pharma chemicals in wastewater
June 10, 2010Manufacturing and Production manufacturing, manufacturing compliance
Wastewater from pharmaceutical manufacturing facilities is a major source of drug compounds in the environment, according to a new study …
Digital Pharma: Online clinical collaboration
June 10, 2010Research and Development biomarkers, digital doctors, digital pharma research, proteomic
A new online educational resource will offer researchers across the medical community access to peer-reviewed information on biomarkers. The portal …
NICE rejects GSK’s Revolade
June 10, 2010Sales and Marketing ITP, NICE, Revolade
NICE has rejected GlaxoSmithKline’s Revolade saying in draft guidance that the blood disorder drug’s benefits were unclear. The watchdog assessed …
Pfizer appoints neuroscience research head
June 10, 2010Research and Development Pfizer, appointment, research and development
Pfizer has appointed Dr Michael Ehlers chief scientific officer for neuroscience research. Dr Ehlers most recently served as the George …
NICE says no to GSK breast cancer drug
June 10, 2010Sales and Marketing NICE, Tyverb
NICE has issued final draft guidance restricting use of GlaxoSmithKline’s breast cancer drug Tyverb to clinical trials, citing high cost …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
